As established products accelerate their expansion into overseas markets, and collaboration models such as technology partnerships and localized industrialization continue to take shape, CanSinoBIO’s ...
GSK Philippines recently announced that announced on Tuesday that the Philippine Food and Drug Administration (FDA) has approved its Meningococcal Group B Vaccine (recombinant, adsorbed), for the ...
CanSino Biologics Inc. ('CanSinoBIO,' 06185.HK/688185.SH) released its financial results for the first half of 2026. The Company reported revenue of approximately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results